METHOD OF MICROINVASIVE COMBINED LASER SURGICAL MANAGEMENT OF LOCAL RHEGMATOGENOUS RETINAL DETACHMENT AS A RESULT OF VALVE RUPTURE IN THE PRESENCE OF PARTIAL HEMOPHTHALMIA Russian patent published in 2020 - IPC A61F9/08 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to ophthalmology, and can be used in the presence of local rhegmatogenous retinal detachment with partial hemophthalmias. YAG-laser retinotomy of the whole vitreoretinal splice area with pulse energy 4.0–7.5 mJ with wave length 1,064 nm, pulse duration 4 ns, spot diameter in focal point 8 mcm is performed. Then gas-air tamponade of vitreal cavity is performed with application of gas-air mixture containing 10 % C3F8 with volume of not more than 0.5 ml. Immediately before air-gas swabbing, an intravitreal injection of a recombinant prourokinase – Hemase preparation is carried out, for which 5,000 IU of Hemase is dissolved in 1 ml of 0.9 % solution of sodium chloride, taken 0.1 ml of the obtained solution and diluted with 0.1–0.2 ml 0.9 % solution of sodium chloride. Prepared solution in amount of 0.2–0.3 ml is administered intravitreally once. That is followed by barrier laser coagulation with wave length 532 nm, power 0.1–0.3 W, spot diameter at focal point 200 mcm, pulse duration 0.1 s.

EFFECT: method enables minimizing the surgical intervention, reducing the probability of intra- and postoperative complications and reducing the risk of recurrence of retina detachment.

1 cl, 3 ex